Capricor Therapeutics | CAPR - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Bioline Rx USD 2.63M 24K 2025-09
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cipla INR 59.27B 1.71B 2026-03
Cytokinetics USD 200.58M 4.46M 2026-03
Geron USD 52.07M 6.73M 2026-03
Grifols EUR 1.99B 217.4M 2025-12
Immunic USD 23.33M 2.67M 2025-12
J&J USD 17.44B 1.53B 2026-03
Plus Therapeutics USD 7.11M 1.23M 2025-12
Prothena USD 27.23M 14.95M 2025-12
PTC Therapeutics USD 226.66M 19.64M 2026-03
Sarepta Therapeutics USD 372.37M 480.65M 2026-03